Skip to main content

Aurora Hires Former GeneProt Exec as VP, Business Development

NEW YORK, March 23 – Aurora Biosciences said it has hired William Ettouati, former co-CEO of Geneva Proteomics, as vice president of business development.

Ettouati, who was at the helm of Geneva Proteomics from April to August of last year, will seek to expand Aurora’s business in Europe and develop other strategic alliances, Aurora said. Before his term at GeneProt, Ettouati headed up Ceptyr, a Seattle-based biotech company developing PTP-based therapeutics. 

San Diego-based Aurora has also promoted three executives within its ranks. Christopher Krueger, formerly vice president of strategic alliances and legal affairs, will be Aurora’s general counsel and vice president, strategic alliances; Pamela Fritz has been promoted from senior director, Human Resources to vice president, Human Resources; and Brian Pollok, has been has been promoted from director, Discovery Biology to vice president, Discovery Biology.

Pollok will head up efforts to integrate the scientific and business aspects of Panvera, a Madison, Wisc. -based manufacturer of recombinant protein drug targets and protein drug screening assays, Aurora said.

Aurora Biosciences of San Diego develops and applies proprietary technologies designed to accelerate the discovery of new medicines.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.